Outlook Therapeutics (OTLK) Update / Briefing August 28, 2025 08:30 AM ET Company ParticipantsBob Jahr - CEO & Board of DirectorEddie Hickman - Vice PresidentLawrence Kenyon - EVP & CFOJennifer Kissner - EVP - Medical, Clinical, & Regulatory AffairsDouglas Tsao - Managing DirectorJulian Harrison - Managing DirectorConference Call ParticipantsDaniil Gataulin - Senior Research AnalystKemp Dolliver - Director - Research & Senior AnalystOperatorHello and welcome to Outlook Therapeutics' corporate update confere ...